← Back to Search

Minoxidil 2% Solution and Botanical Hair Regimen in Women With Thinning Hair and Female Pattern Hair Loss/Androgenic Alopecia

N/A
Waitlist Available
Research Sponsored by Galderma Laboratories, L.P.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at week 4, 6 and 12
Awards & highlights
All Individual Drugs Already Approved
No Placebo-Only Group

Summary

The purpose of this study is to characterize the effect of Minoxidil 2% Solution and Botanical Hair Solution Regimen in women with thinning hair and female pattern hair loss/androgenic alopecia (Ludwig I and II).

Eligible Conditions
  • Hair Loss

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at week 4, 6 and 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and at week 4, 6 and 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change From Baseline in Investigator's Rating of Global Photographs at Week 12
Secondary study objectives
Change From Baseline in Participant Rating at Week 12
Mean Change From Baseline in Shed Hair Count
Number of Participants With Adverse Events (AEs)
+1 more

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Minoxidil
FDA approved

Find a Location

Who is running the clinical trial?

Galderma Laboratories, L.P.Lead Sponsor
48 Previous Clinical Trials
9,166 Total Patients Enrolled
Galderma R&DLead Sponsor
302 Previous Clinical Trials
60,599 Total Patients Enrolled
Warren Winkelman, MD, PhD, MBAStudy DirectorGalderma R&D
1 Previous Clinical Trials
63 Total Patients Enrolled
~6 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top